E
GRTS

Ergoteles’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Ergoteles’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-58,700
Closed -$151K – 1988
2022
Q3 		$151K Sell
58,700
-188,200
-76% -$599K 0.01% 1274
2022
Q2 		$597K Buy
246,900
+215,800
+694% +$567K 0.02% 761
2022
Q1 		$128K Buy
+31,100
New +$165K ﹤0.01% 1080
2021
Q1 		– Sell
-17,700
Closed -$70K – 1121
2020
Q4 		$70K Buy
+17,700
New +$53.5K ﹤0.01% 635

Other funds holding GRTS

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Ergoteles's GRTS Position: Q4 2022 in Review

Ergoteles sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2022, closing a stake of 58,700 shares — an estimated $151K sold.

Ergoteles first reported a position in GRTS in Q4 2020 and held it in 4 quarters. The position peaked at $597K in Q2 2022. 91 funds tracked by Wall St. Rank hold GRTS as of Q4 2022.

  • Ergoteles reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Ergoteles sold 58,700 Gritstone bio, Inc. Common Stock shares in Q4 2022, an estimated $151K.
  • Ergoteles first reported a position in Gritstone bio, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
  • Ergoteles's Gritstone bio, Inc. Common Stock position peaked at $597K in Q2 2022.
  • 91 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.